An increase to 0.45 SDS (-0.65 to 1.11 SDS) was observed in serum AMH after 3 months of chemotherapy in patients with SR/IR ALL, but no significant changes were seen in boys with HR-ALL or NHL (Figure 4A). This evidence concerns the gene AMH and non-Hodgkin lymphoma.